Phathom Pharmaceuticals, Inc.
PHAT—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-3.03
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$175.11M
Net income
$-221.25M
Net margin
-126.3%
Gross margin
87.1%
Dividends & financials
Phathom Pharmaceuticals, Inc. (PHAT) reported revenue of $175.11M and net income of $-221.25M, or $-3.03 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
